Geron Corp. (GERN)
1.525
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 13:51
Geron Net Income (Quarterly) : -16.68M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -16.68M |
| March 31, 2026 | -3.642M |
| December 31, 2025 | -31.14M |
| September 30, 2025 | -18.43M |
| June 30, 2025 | -16.38M |
| March 31, 2025 | -19.84M |
| December 31, 2024 | -25.35M |
| September 30, 2024 | -26.45M |
| June 30, 2024 | -67.38M |
| March 31, 2024 | -55.39M |
| December 31, 2023 | -51.97M |
| September 30, 2023 | -44.80M |
| June 30, 2023 | -49.23M |
| March 31, 2023 | -38.12M |
| December 31, 2022 | -42.64M |
| September 30, 2022 | -41.05M |
| June 30, 2022 | -28.12M |
| March 31, 2022 | -30.10M |
| December 31, 2021 | -32.02M |
| September 30, 2021 | -26.70M |
| June 30, 2021 | -29.57M |
| March 31, 2021 | -27.82M |
| December 31, 2020 | -23.79M |
| September 30, 2020 | -19.65M |
| June 30, 2020 | -15.82M |
| Date | Value |
|---|---|
| March 31, 2020 | -16.36M |
| December 31, 2019 | -29.07M |
| September 30, 2019 | -15.18M |
| June 30, 2019 | -14.24M |
| March 31, 2019 | -10.06M |
| December 31, 2018 | -7.30M |
| September 30, 2018 | -5.597M |
| June 30, 2018 | -6.934M |
| March 31, 2018 | -7.186M |
| December 31, 2017 | -7.429M |
| September 30, 2017 | -6.899M |
| June 30, 2017 | -6.405M |
| March 31, 2017 | -7.183M |
| December 31, 2016 | -8.482M |
| September 30, 2016 | -3.576M |
| June 30, 2016 | -8.637M |
| March 31, 2016 | -8.842M |
| December 31, 2015 | -8.468M |
| September 30, 2015 | 27.18M |
| June 30, 2015 | -9.356M |
| March 31, 2015 | -9.315M |
| December 31, 2014 | -8.947M |
| September 30, 2014 | -9.549M |
| June 30, 2014 | -8.734M |
| March 31, 2014 | -8.44M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Precigen, Inc. | 20.07M |
| Editas Medicine, Inc. | -18.23M |
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 57.48M |
| Total Expenses (Quarterly) | 74.16M |
| EPS Diluted (Quarterly) | -0.0249 |
| Enterprise Value | 925.59M |
| Gross Profit Margin (Quarterly) | 94.94% |
| Profit Margin (Quarterly) | -29.02% |
| Earnings Yield | -6.86% |
| Normalized Earnings Yield | -5.725 |